Not recruiting
Chronic hepatitis C
Not recruitingComparing bemnifosbuvir-ruzasvir and sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in adult patients
InvestigationalNo placebo
Comparing bemnifosbuvir-ruzasvir and sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in adult patients
InvestigationalNo placebo
- Disease:Chronic hepatitis C
- Substances:BemnifosbuvirRuzasvir+2
Countries:
Greece
Greece- Participants:18–64 years · 65+ years
- Substances:Bemnifosbuvir
- Sponsor:Atea Pharmaceuticals Inc.



